USFDA approves Nucala to treat hypereosinophilic syndrome
The approval granted to GlaxoSmithKline is the first approval for HES patients in nearly 14 years
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.